News

One of life’s simple pleasures is camping due to the campfires, night air, and digital detox; however, for those with sleep ...
Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.
GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.
Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...
With global demand for GLP-1-based drugs rising, Indian CDMOs are ramping up peptide capabilities ahead of key patent ...
An investigation has found at least 74 complaints have been made to hospital managers across England in the past 12 months.